首页 >
法规速递
-
Page: Extensions of marketing authorisations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Biosimilar medicines: Overview-2026/3/27
2026-03-30查看详情 > -
Page: Reflection paper on a tailored clinical approach in biosimilar development-2026/3/27
2026-03-30查看详情 > -
Page: Post-authorisation efficacy studies: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Type-II variations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Document: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes-2026/3/27
2026-03-30查看详情 > -
Document: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure-2026/3/27
2026-03-30查看详情 > -
Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure-2026/3/27
2026-03-30查看详情 > -
Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes-2026/3/27
2026-03-30查看详情 > -
Document: Template - Application for transfer of marketing authorisation from transferor to transferee - cover letter (human)-2026/3/27
2026-03-30查看详情 >
